Venus launches arthritis drug Trois
Chandigarh: Pharma major Venus Remedies today launched a new drug Trois for treatment of arthritis.
The drug would provide relief from all kinds of arthritic pains, company`s Joint Managing Director and Director (Research) Manu Chaudhary said in a statement.
The problem of arthritis is a constantly growing epidemic in India, he said.
"...We felt the pressing need to develop an alternative solution for rheumatic disorders and related infections, thus have come up for the first time with a topical nano emulsion `Trois` to relieve arthritic pain."
According to reports, almost 15 per cent of the Indian population is suffering with this crippling disease.
"With the kind of response we are getting for this revolutionary nano tech emulsion in pain management as topical pain killer in arthritis, we are hopeful of capturing a significant share of the rheumatoid arthritis drug market in India, which is estimated to grow up to USD 672 million in 2013," company`s CFO Dheeraj Aggarwal said.
The Panchkula-based company has already filed patents for Trois in the major markets across the world. "Based on the regulatory approvals, we are soon going the launch our products in the international markets as well," he said.